Loading your page…
G03DC02
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 48 medicines
PHARMAC · 14 medicines
AEMPS · 10 medicines
TFDA · 7 medicines · Historical list
CBG-MEB · 4 medicines
HSA · 4 medicines
AIFA · 3 medicines
ALIMS · 3 medicines
SFDA · 2 medicines · Historical list
EMA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
173 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Norethindrone | United States | 0.35MG | tablet | Marketed | Xiromed |
| Norethindrone Acetate | United States | 5MG | tablet | Marketed | Xiromed |
| Norethindrone Acetate and Ethinyl EstradiolCombination | United States | 0.02MG; 1MG, 0.03MG; 1.5MG | tablet | Marketed | Glenmark Pharms LTD |
| Norethindrone Acetate and Ethinyl EstradiolCombination | United States | 0.0025MG; 0.5MG, 0.005MG; 1MG | tablet | Marketed | Barr Labs INC |
| Norethindrone Acetate and Ethinyl EstradiolCombination | United States | 0.02MG,0.03MG,0.035MG; 1MG,1MG,1MG, 0.02MG; 1MG, 0.03MG; 1.5MG | tablet | Marketed | Xiromed |
| Norethindrone and Ethinyl EstradiolCombination | United States | 0.035MG,0.035MG,0.035MG; 0.5MG,0.75MG,1MG, 0.035MG; 0.4MG, 0.035MG; 0.5MG … | tablet | Marketed | Xiromed |
| Norethindrone and Ethinyl Estradiol and Ferrous FumarateCombination | United States | 0.025MG; 0.8MG | tablet, chewable | Marketed | Xiromed |
| Norethindrone and Ethinyl Estradiol and Ferrous FumarateCombination | United States | 0.035MG; 0.4MG | tablet | Marketed | Naari Pte |
| Norethindrone and Ethinyl Estradiol (10/11)Combination | United States | 0.035MG,0.035MG; 0.5MG,1MG | tablet | Marketed | Watson Labs Teva |
| Norethindrone Acetate and Ethinyl Estradiol and Ferrous FumarateCombination | United States | 0.02MG; 1MG | tablet | Marketed | Amneal Pharms |
| Norethindrone Acetate and Ethinyl Estradiol and Ferrous FumarateCombination | United States | 0.02MG; 1MG | capsule | Marketed | Glenmark Pharms LTD |
| Norethindrone and MestranolCombination | United States | 0.05MG; 1MG | tablet | Not marketed | Watson Labs |
| Norethindrone and MestranolCombination | United States | 0.05MG; 1MG | tablet | Not marketed | Watson Labs |
| Norethindrone and Ethinyl EstradiolCombination | United States | 0.035MG; 0.4MG, 0.035MG; 0.5MG, 0.035MG; 1MG | tablet | Not marketed | Watson Pharms Teva |
| Norethindrone and Ethinyl Estradiol (10/11)Combination | United States | 0.035MG,0.035MG; 0.5MG,1MG | tablet | Not marketed | Watson Labs |
| Norethindrone and Ethinyl Estradiol (7/14)Combination | United States | 0.035MG,0.035MG; 0.5MG,1MG | tablet | Not marketed | Watson Labs |
| Norethindrone and Ethinyl Estradiol (7/14)Combination | United States | 0.035MG,0.035MG; 0.5MG,1MG | tablet | Not marketed | Watson Labs Teva |
| Norethindrone Acetate and Ethinyl Estradiol and Ethinyl Estradiol and Ferrous FumarateCombination | United States | 0.01MG,0.01MG; 1MG,N/A | tablet | Not marketed | Xiromed |
| Estradiol and Norethindrone AcetateCombination | United States | 0.5MG; 0.1MG, 1MG; 0.5MG | tablet | Marketed | Teva Pharms USA |
| Nor-QD | United States | 0.35MG | tablet | Marketed | Teva Branded Pharm |
| Norethindrone Acetate; Ethinyl Estradiol; Ethinyl Estradiol; Ferrous FumarateCombination | United States | 75MG | tablet | Tentative approval | Glenmark Pharms LTD |
| Alyacen 777Combination | United States | 0.75MG; 0.035MG, 1MG; 0.035MG | tablet | Marketed | Glenmark Pharms LTD |
| Camila | United States | 0.35MG | tablet | Marketed | DR Reddys Labs SA |
| Emzahh | United States | 0.35MG | tablet | Marketed | Aurobindo Pharma |
| Errin | United States | 0.35MG | tablet | Marketed | DR Reddys Labs SA |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, Health Canada, HSA, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
